Matthew Stephen Young - 01 Apr 2022 Form 4 Insider Report for Nutex Health, Inc. (NUTX)

Reporting relationship: Director
Issuer ticker: NUTX
Reported as of: 01 Apr 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 05 Apr 2022, 16:03:17 UTC
Source filing: View source filing
Reporting owner signature: /s/ Matthew Stephen Young

Key filing fact

Matthew Stephen Young filed Form 4 for Nutex Health, Inc. (NUTX) on 05 Apr 2022.

Key facts

This page summarizes Matthew Stephen Young's Form 4 filing for Nutex Health, Inc. (NUTX).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 05 Apr 2022, 16:03.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NUTX transaction

Common Stock

Award

Transaction value
Shares: +42,134,210
Change %
Price
Shares after: 42,134,210
Date: 01 Apr 2022
Ownership: By Premier Macy Management Holdings, LLC
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

At the closing of the business combination pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), as described in the Issuer's definitive proxy statement on Schedule 14A filed with the Securities and Exchange Commission on February 14, 2022, as supplemented, the reporting person received 3.571428575 shares of Common Stock of the Issuer in exchange for each membership interest in Nutex Health Holdco LLC.